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Counting Cavitating Lacunes Underestimates the Burden of
Lacunar Infarction
Gillian M. Potter, MBChB, BSc (Hons), MRCP, FRCR; Fergus N. Doubal, MBChB, MRCP;
Caroline A. Jackson, MSc, PhD; Francesca M. Chappell, MSc; Cathie L. Sudlow, DPhil, FRCP;
Martin S. Dennis, MD, FRCP(E); Joanna M. Wardlaw, MD, FRCR, FRCP, FMedSci
Background and Purpose—On brain imaging, lacunes, or cerebrospinal fluid–containing cavities, are common and are
often counted in epidemiological studies as old lacunar infarcts. The proportion of symptomatic lacunar infarcts that
progress to lacunes is unknown. Noncavitating lacunar infarcts may continue to resemble white matter lesions.
Methods—We identified patients with acute lacunar stroke, with or without an acute lacunar infarct on computed
tomography or MRI, who had follow-up imaging. A neuroradiologist classified lacunar infarcts progressing to definite
or possible cavities on follow-up imaging. We tested associations between cavitation and patient-related, stroke-related,
and imaging-related features, including other features of small vessel disease.
Results—Among 90 patients (mean age 67 years), any cavitation was present on follow-up imaging in 25 (28%), and
definite cavitation in 18 (20%). Definite cavitation was associated with increasing time to follow-up imaging (median
228 days, range 54 to 1722, versus no cavitation 72 days, range 6 to 1440; P0.0003) and deep cerebral atrophy
(P0.03) but not with age, stroke severity, larger initial infarct size, or other features of small vessel disease.
Hypertension and diabetes were negatively associated with cavitation (P0.01 and 0.02, respectively).
Conclusions—Definite cavitation occurs in one fifth of symptomatic lacunar ischemic strokes, implying that most continue
to resemble white matter lesions. Epidemiology and pathophysiology studies of lacunar stroke, which have only counted
lacunes as lacunar infarcts, may have substantially underestimated by as much as 5 times the true burden of lacunar
stroke disease. (Stroke. 2010;41:267-272.)
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Alacune is commonly defined as a small, deep, 3- to 20-mm(or in some cases, 3- to 15-mm) cerebrospinal fluid
(CSF)–containing cavity. The term lacune was first used by
Dechambre in 18381 and later in 1901 by Marie,2 who suggested
these could be attributable to infarcts. Sixty years later, Fisher
defined lacunes pathologically as infarcts, either clinically silent
or symptomatic, resulting from occlusion of a penetrating branch
of a cerebral artery.3–5 The term lacune is often used inter-
changeably with the terms lacunar infarct and lacunar stroke.
Tissue loss replaced by CSF (or near-CSF) is also known
radiologically as cerebromalacea and can affect gray or white
matter, but this term is usually applied to cortical infarcts.
Silent lacunes (on imaging or histopathology, without clear
evidence of relevant stroke symptoms) are often termed silent
lacunar infarcts or silent brain infarcts. Silent lacunes are
frequently seen in healthy older people, occur in 8% to 28% of
the general population, are associated with increasing age,
hypertension, and subtle deficits in physical and cognitive
function, and more than double the risk of stroke and dementia.6
In most studies of silent brain infarcts, there is no definitive
pathological evidence that the lesion was attributable to
infarction.
The association between clinically evident lacunar ische-
mic stroke and silent lacunes is unclear because the propor-
tions in whom the symptomatic lacunar infarct progresses to
a cavity and in whom the lesion continues to resemble a white
matter lesion are unknown. This has significant implications
for epidemiology (including risk factor) and pathogenesis
studies of lacunar infarction and cerebral small vessel disease,
in which it is common practice to count lacunes and only
consider these as silent lacunar infarcts, omitting to correlate
these with symptoms.
We investigated the proportion of symptomatic lacunar
strokes progressing to lacunes and assessed patient-related,
stroke-related, and imaging-related associations of cavitation.
Subjects and Methods
We identified patients with acute lacunar ischemic stroke, diagnosed
after clinical and radiological evaluation, with baseline and follow-up
MRI or computed tomography (CT) brain imaging, from 2 studies: a
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prospective register of consecutive stroke patients presenting to an
academic teaching hospital,7 and a prospective study of acute lacunar
stroke.8 A stroke physician assigned a classification using the Oxford-
shire Community Stroke Project Classification,9 measured the National
Institutes of Health Stroke Scale score (NIHSS), and assessed vascular
risk factors. Written consent was obtained from all patients. Both studies
were approved by the local research ethics committee.
We included patients with baseline imaging with either MRI
(diffusion-weighted imaging [DWI], T2-weighted imaging, and
fluid-attenuated inversion recovery [FLAIR]) or CT brain imaging.
We included patients with or without an acute lacunar infarct on MRI
(because the high sensitivity of magnetic resonance enabled us to
exclude as fully as possible patients with cortical infarction), but on
CT, we only included patients with a visible recent lacunar infarct in
the appropriate area for symptoms (because the low sensitivity of a
negative CT would not allow us to exclude cortical stroke, which
may give rise to lacunar-type symptoms).10 Baseline and follow-up
imaging was with either MRI (including T1-weighted, T2-weighted,
FLAIR, and gradient echo sequences) or CT (parameters published
previously).7,8 Patients with baseline DWI-positive MRI and
follow-up MRI were considered to represent a “pure” subgroup
because diagnosis was most sensitive and specific for stroke subtype.
The inclusion of the larger group in whom baseline imaging was
either CT positive or magnetic resonance negative enabled us to
increase sample size, study power, and generalizability.
A neuroradiologist (G.M.P.) recorded site and diameter of the
acute index symptomatic lacunar infarct, white matter lesions
(WML), enlarged perivascular spaces, cerebral atrophy, lacunes
(separate from index lesion), and spongiform lesions (separate from
index lesion). Acute lacunar infarcts were defined as round or ovoid
lesions of increased signal relative to white matter on DWI, FLAIR,
or T2-weighted imaging, or decreased attenuation relative to white
matter on CT, 3 to 20 mm in diameter, in the white matter, basal
ganglia, or brain stem. WMLs were rated on MRI (0 to 3 on Fazekas
scale11) or CT (0 to 2 on van Swieten scale12). Enlarged perivascular
spaces, defined as 2 mm round or linear CSF–isointense lesions
along the course of penetrating arteries, were rated on MRI in the
basal ganglia and centrum semiovale13 (0 to 4, where 0none,
110, 220, 320 to 40, and 440); atrophy was also rated
(0 to 3 on validated scale,14 where 0none and 3severe). Lacunes
were defined as round or ovoid lesions of CSF attenuation/signal
measuring 3 to 20 mm in the white matter, basal ganglia, or brain
stem; correlation with appropriate symptoms was not sought. Coding
was performed unblinded to clinical symptoms (to be certain of
correct identification of the index lesion) but blind to all other
clinical data.
At follow-up, a “definite” cavity was defined as a lesion of CSF,
or near-CSF, attenuation on CT, or of CSF signal on T2-weighted
imaging or FLAIR MRI, at the site of the index infarct (Figure 1). A
“possible” cavity was defined on FLAIR as a lesion of spongiform
appearance with areas of marked hypointensity showing early
confluence at the site of the index infarct. “Definite” (CT and MRI)
and “possible” cavitation (FLAIR only) were considered together as
“any evidence of cavitation.” In cases of uncertainty, images were
reviewed by a second experienced neuroradiologist (J.M.W.). La-
cunes developing elsewhere in the brain between baseline and
follow-up imaging were also recorded; correlation with appropriate
symptoms was not sought for these lesions.
Statistical Analysis
We calculated proportions with any evidence of, and definite, cavitation
(with 95% CIs) in the whole group, the “pure” subgroup and the
subgroup with an index infarct. We assessed statistical significance of
differences in baseline characteristics and imaging features in patients
with “definite” and any (“definite” plus “possible”) cavitation of the
index lacunar infarct in the whole group and “pure” subgroup. We used
the Student t test for continuous variables, the Mann–Whitney U test for
non-normally distributed continuous variables, and the 2 test for
dichotomous variables. We performed multivariate analysis using logis-
tic regression to determine independent predictors of cavitation, allow-
ing one variable per 5 outcome events. We obtained adjusted odds ratios
(ORs) and 95% CIs, comparing patients with “any” and “definite”
cavitation versus those without. For “any” cavitation, we used signifi-
cant variables from univariate analysis (hypertension, diabetes, time to
follow-up), and concomitant lacunes at baseline and deep atrophy,
considered more likely than other features to be associated with
cavitation; for “definite” cavitation, we included time to follow-up
(significant on univariate analysis), hypertension (significant in univar-
iate analysis for “any” cavitation), and deep atrophy. We dichotomized
scores for WMLs (Fazekas 0 to 1 versus 2 to 3; van Swieten 0 versus 1
to 2), brain tissue loss, and enlarged perivascular spaces (0 to 2 versus
3 to 4) attributable to low frequencies. We also examined the proportion
with any progression of cavitation of existing “spongiform” nonindex
lesions. All statistical analyses were performed using Minitab (Version
15; Minitab Inc).
Results
Ninety patients met our inclusion criteria. Mean age was
6712 years, 48 (53%) had a history of hypertension, 18
(20%) diabetes, and 12 (13%) a history of previous stroke. A
“pure” subgroup of 47 of 90 (52%) patients had a DWI-
positive acute lacunar infarct and follow-up MRI (Table 1); 6
had baseline MRI and follow-up CT; and 21 had baseline CT
with either CT or MRI follow-up.
Of the 74 of 90 (82%) patients with an acute index lacunar
infarct, 45 (60%) were in the centrum semiovale, 18 (24%) in the
internal capsule, 9 (12%) in the thalamus, and 3 (4%) in the brain
stem. Of the 16 of 90 MRI-negative patients, follow-up MRI
was normal in 15 and showed a noncavitating lesion in an
appropriate site for original symptoms in one (Table 1).
On follow-up imaging, 18 of 90 (20%; 95% CI, 12% to
28%) patients showed definite, and a further 7 possible,
cavitation, making a total of 25 of 90 (28%; 95% CI, 19% to
37%) with any evidence of cavitation. In the “pure” sub-
Figure 1. Examples of definite (A) and
possible (B) cavities in the centrum
semiovale on FLAIR MRI, both with con-
comitant WML. C, Cavity in the right
thalamus on CT.
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group, 7 of 47 (18%) had definite cavitation, and an addi-
tional 7 showed possible cavitation, making a total of 14 of 47
with any evidence of cavitation (30%; 95% CI, 17% to 43%).
In sensitivity analyses to exclude patients without a DWI-
positive lesion at baseline (ie, 74 patients with visible lacunar
infarction), definite cavitation was visible in 18 (24%; 95%
CI, 15% to 34%), and possible cavitation in an additional 7.
Therefore, 25 of 74 (34%; 95% CI, 23% to 45%) showed any
evidence of cavitation. In one case, an acute lacunar infarct on
baseline CT was not visible on follow-up MRI.
In the entire group of 90 patients, cavitation was associated
with increasing time to follow-up imaging in those with both
definite and any evidence of cavitation on univariate analysis
(P0.0003 and P0.03, respectively; Tables 2 and 3) and with
deep atrophy in patients with definite cavitation (P0.03).
Figure 2 shows the time from stroke onset to follow-up imaging
in patients with any evidence of, and definite, cavitation. In
patients with any evidence of cavitation, hypertension and
diabetes were negatively associated with cavitation (P0.01 and
0.02, respectively). In multivariate analysis, increasing time to
follow-up and deep atrophy remained significant for patients
with definite cavitation (OR, 1.81; 95% CI, 1.12% to 2.92% and
OR, 3.24; 95% CI, 1.02% to 10.27%). No other patient-related,
stroke-related, or imaging-related variables (age, NIHSS, and all






Cavitation of Infarct at
Follow-Up
Baseline Follow-Up Lesion n Yes No None Possible Definite
MRI MRI Yes 47* 47 0 33 7 7
MRI CT Yes 6 6 0 4 n/a 2
MRI MRI No 16 1 16 1 0 0
CT MRI n/a 10 9 1 6 0 3
CT CT n/a 11 11 0 5 n/a 6
*“Pure” subgroup.
Table 2. Clinical and Imaging Associations of Cavitation in Patients With Any Evidence of Cavitation (n90)
n Where
Not 90







Age in years (meanSD) 68.312.3 66.812 t test 0.59
Male (%) 16 (64) 38 (58) 2 0.81
NIHSS median score (range) 86 1 (0–11) 2 (0–9) Mann–Whitney 0.66
Vascular risk factors
Stroke (%) 1 (4) 11 (17) Fisher’s 0.17
Hypertension (%) 8 (32) 40 (62) 2 0.01
Diabetes (%) 1 (4) 17 (26) Fisher’s 0.02
Imaging parameters
Onset to assessment, median days (range) 16 (0–43) 9 (0–104) Mann–Whitney 0.56
Onset to baseline imaging, median days (range) 17 (0–43) 9 (0–104) Mann–Whitney 0.44
Onset to follow-up imaging, median days (range) 102 (39–1722) 74 (6–1440) Mann–Whitney 0.03
Lacunar size mm (meanSD) 74 9.93.2 9.74.2 t test 0.87
Other lacunes baseline 9 (36) 22 (34) 2 0.85
Deep* WML dichotomized 0:1 vs 2:3 80 7 (27) 24 (39) 2 0.85
Periventricular* WML dichotomized 0:1 vs 2:3 80 13 (68) 35 (57) 2 0.39
Anterior† WML dichotomized 0 vs 1:2 10 3 (50) 3 (75) Fisher’s 0.57
Posterior† WML dichotomized 0 vs 1:2 10 1 (17) 2 (50) Fisher’s 0.5
Deep atrophy dichotomized 0:1 vs 2:3 11 (44) 24 (37) 2 0.54
Superficial atrophy dichotomized 0:1 vs 2:3 5 (20) 11 (17) 2 0.74
Basal ganglia EPVS dichotomized 0:2 vs 3:4 80 3 (16) 18 (30) Fisher’s 0.37
Centrum semiovale EPVS dichotomized 0:2 vs 3:4 80 8 (42) 22 (36) 2 0.64
*Fazekas scale; †van Swieten scale.
EPVS indicates enlarged perivascular spaces.
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other features of small vessel disease) were associated with any
evidence of, or definite, cavitation.
In the subgroup of 47 patients with a positive baseline
diffusion scan and follow-up MRI, definite cavitation was
associated on univariate analysis with increasing time to
follow-up (P0.009) and superficial atrophy (P0.03). In
those with any evidence of cavitation, hypertension was
negatively associated with cavitation (P0.009). No other
clinical or imaging features were associated with cavitation in
either the whole group or “pure” subgroup.
At baseline, 13 of 90 patients (14%) had subcortical
spongiform lesions separate from the index acute lacunar
infarct (single lesion in 10; 2 lesions in 3). Progression to a
definite cavity on follow-up occurred in 2 of these patients,
but in neither patient did the index lesion show any evidence
of cavitation. From the 11 spongiform lesions that did not
progress to a definite cavity, the index lacunar infarct showed
progression to a definite cavity in 2 patients.
At baseline, 31 of 90 (34%) patients had concomitant
lacunes. Of these 31, 18 (58%) had higher WML scores than
the 17 of 59 (29%) without concomitant lacunes at baseline
(2 P0.007); 4 of 31 (4%) patients developed new lacunes
between baseline and follow-up imaging (unrelated to the
index lesion) over an interval ranging from 76 to 185 days.
Discussion
The proportion of symptomatic lacunar infarcts that undergo
cavitation to lacunes is unknown. In this study, one fifth of
patients with acute lacunar ischemic stroke showed definite
cavitation on follow-up imaging at a median of 227 days (range
54 to 1722) after stroke onset. In a “pure” subgroup (DWI-
positive infarct with follow-up MRI), 15% of patients showed
definite cavitation. Definite cavitation was associated with in-
creasing time to follow-up in univariate and multivariate analy-
sis, but not with age, NIHSS, lesion size or location, or other
features of cerebral small vessel disease, including other lacunes.
Table 3. Clinical and Imaging Associations of Cavitation in Patients With Definite Cavitation (n90)








Age in years (meanSD) 69.611.1 66.612.3 t test 0.33
Male (%) 13 (72) 41 (57) 2 0.23
NIHSS median score (range) 86 2 (0–11) 1 (0–9) Mann–Whitney 0.61
Vascular risk factors
Stroke (%) 1 (6) 11 (15) Fisher’s 0.45
Hypertension (%) 6 (33) 42 (58) 2 0.056
Diabetes (%) 1 (6) 17 (24) Fisher’s 0.11
Imaging parameters
Onset to assessment, median days (range) 17 (0–43) 9 (0–104) Mann–Whitney 0.43
Onset to baseline imaging, median days (range) 18(0–43) 10 (0–104) Mann–Whitney 0.49
Onset to follow-up imaging, median days (range) 227 (54–1722) 72 (6–1440) Mann–Whitney 0.0003
Lacunar size mm (meanSD) 74 9.282.82 9.954.14 t test 0.44
Other lacunes at baseline 6 (33) 25 (35) 2 0.91
Deep* WML dichotomized 0:1 vs 2:3 80 4 (39) 27 (40) 0.76
Periventricular* WML dichotomized 0:1 vs 2:3 80 8 (67) 40 (59) Fisher’s 0.75
Anterior† WML dichotomized 0 vs 1:2 10 3 (50) 3 (75) Fisher’s 0.57
Posterior† WML dichotomized 0 vs 1:2 10 1 (17) 2 (50) Fisher’s 0.5
Deep atrophy dichotomized 0:1 vs 2:3 11 (61) 24 (33) 2 0.03
Superficial atrophy dichotomized 0:1 vs 2:3 5 (28) 11 (15) 2 0.24
Basal ganglia EPVS dichotomized 0:2 vs 3:4 80 3 (25) 3 (25) 18 (26) 1
Centrum semiovale EPVS dichotomized 0:2 vs 3:4 80 5 (42) 25 (37) 2 0.75
*Fazekas scale; †van Swieten scale.
EPVS indicates enlarged perivascular spaces.
Figure 2. Time to follow-up imaging in patients with and without
definite cavitation.
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The association with increasing time to follow-up remained
significant in the “pure” subgroup. If these proportions are
similar in other populations, up to four fifths of symptomatic
lacunar infarcts may resemble, and be misidentified as, WML at
any time up to 5 years after stroke, possibly longer.
Definite cavitation was associated with deep atrophy in
univariate and multivariate analysis and with superficial
atrophy in the “pure” subgroup. Our data indicate that age,
stroke severity, and other features of small vessel disease
(WML, concomitant lacunes, and enlarged perivascular
spaces) were not linked to cavitation. On the other hand,
hypertension was negatively associated with cavitation in
patients with any evidence of cavitation (in both the whole
group and “pure” subgroup) and diabetes in the whole group.
The main strengths of our study are that patients were
carefully characterized clinically to be certain of the clinical
diagnosis of lacunar stroke, all data were collected according
to prespecified criteria, and most patients had baseline MRI,
including diffusion. Thus, we can pinpoint precisely when the
index lesion started and follow its evolution with precision.
The 2 studies from which these data are derived were
performed prospectively in the same hospital, using the same
data collection, case ascertainment, diagnostic methods, phy-
sicians, radiologists, and imaging equipment. We tested
associations in the whole, as well as “pure” subgroup and
found that they were similar.
Potential limitations were inclusion of a small proportion
of patients without a lesion on MRI at baseline; some patients
with nonlacunar stroke may have been inadvertently in-
cluded, despite careful clinical characterization. This may
have meant we underestimated the proportion of patients with
cavitation. However, after excluding MRI-negative patients,
proportions with any evidence of and definite cavitation were
similar to the whole group, and to the “pure” subgroup, with
overall point estimates 15% to 33%.
Minimum time to follow-up imaging was relatively short,
but several patients without definite cavitation had follow-up
imaging at 4 years, and we identified patients with definite
cavitation at 54 days. Sample size was relatively small and
precluded more complex analyses, so we cannot exclude
weak associations between cavitation and imaging-, stroke-,
or patient-related features. We were unable to investigate the
influence of some factors (eg, duration of symptoms or
contrast enhancement) because this information was not
collected. Follow-up timing was not fixed, with variable
times to follow-up; in the study of lacunar stroke, follow-up
was at between one and 3 months, and all patients were
recalled for imaging (although not all attended), whereas in
the stroke registry, follow-up mostly occurred if the patient
developed new symptoms. These selection criteria in the
original studies may have influenced cavitation detection
rates. Larger studies with fixed follow-up time points are
required to obtain more precise data on cavitation.
No previous studies have examined cavitation rates in symp-
tomatic lacunar ischemic stroke, so there is little information
with which to draw comparisons. Longitudinal studies show that
WML and lacunes increase in number over time, with hyper-
tension (among others) being a risk factor for new lacunes, and
diabetes and hypertension being risk factors (among others) for
WML progression.15,16 We found that increased WML severity
was associated with concomitant lacunes on baseline imaging, in
agreement with previous studies.17,18 Gouw15 found that WML
progression was modestly correlated with number of new
lacunes at follow-up; we were unable to investigate for such a
correlation. The apparent coassociation of lacunes and WML
suggests that lacunes may represent the extreme end of a
spectrum of small vessel changes.
Factors associated with cavitation have been investigated
in multiple sclerosis; in longitudinal studies, a ring-enhancing
lesion pattern is associated with cavity development,19–22 but
predictive power is limited because of variability in cavity
development, with some evidence that cavitation is patient-
specific. Differences in multiple sclerosis lesion evolution in
the same patient have also been demonstrated, suggesting
local inflammatory reaction or location may be more relevant
than individual susceptibility in leading to permanent axonal
loss.23 Duration of symptoms may influence whether cavita-
tion occurs (we did not record this), although we found no
association with NIHSS, another marker of stroke severity. In
animals, duration of middle cerebral artery occlusion has
been shown to influence infarct cavitation.24
The molecular processes underlying cerebral tissue damage
and repair, through the stages of tissue infarction and “rarefac-
tion,” leading to gliosis and cavitation, are complex, and as yet
incompletely identified.25 Histologically, a phase of chronic
inflammation, including cavitation, was identified from 10 days
to 53 years in patients with cortical and lacunar infarction.26 In
our study, the earliest time at which a lesion demonstrated any
evidence of cavitation was 39 days, and 54 days for definite
cavitation. Matrix metalloproteinases are important factors for
tissue remodeling implicated in all main cerebrovascular dis-
eases including ischemia and WML in vascular dementia.27,28
Higher levels of matrix metalloproteinase-9 may be related to
neurological deterioration in the first 7 days after acute lacunar
infarction, but there is no information on whether high matrix
metalloproteinase levels are associated with cavitation.29
Thirteen patients in our study had spongiform lesions (possi-
ble cavities) separate from the index lesion at baseline; in 2
patients, these progressed to definite cavities, but the index
lesion showed no cavitation. Similarly, 2 patients with definite
cavitation of the index lesion showed no progression to cavita-
tion in nonindex spongiform lesions. Cavitation may therefore
occur on a “per lesion” rather than “per patient” basis.
What are the implications if only one of 5 acute symptom-
atic lacunar infarcts becomes a cavity and the other 4 continue
to resemble WML? In epidemiology (including risk factor)
and pathophysiology studies of lacunar infarction, which only
count lacunes as old lacunar infarcts, the true burden of
lacunar disease may be underestimated by as much as 5 times.
With the difficulties in distinguishing between WML and
noncavitated lacunar infarction, consideration should be
given to abandoning the term WML in favor of a term such
as small vessel changes, correlating acute lacunar infarcts,
WML, and lacunes with symptoms wherever possible. Our
findings should be confirmed in larger prospective studies of
acute lacunar stroke, with follow-up at prespecified time
intervals.
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Summary
Lacunes are often counted in epidemiological studies as old
lacunar infarcts, but we found definite cavitation of symp-
tomatic lacunar infarcts occurring in only one fifth of pa-
tients; most lacunar infarcts may continue to resemble WML.
The true burden of lacunar stroke disease on imaging may
thus be substantially underestimated in studies that only count
lacunes. We found that cavitation was associated with in-
creasing time to follow-up imaging and deep cerebral atro-
phy. Larger prospective studies, with prespecified follow-up
intervals, are required.
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